New immune drug trial challenges standard chemo for lung cancer
NCT ID NCT03088540
Summary
This large, completed Phase 3 trial tested whether a new immunotherapy drug (cemiplimab) works better than standard platinum-based chemotherapy as the first treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have high levels of a marker called PD-L1. The study directly compared how long patients lived (overall survival) and how long their cancer was kept from growing (progression-free survival) between the two treatment approaches. It involved over 700 patients globally who had not received prior systemic treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clincial Study Site
Viña del Mar, Chile
-
Clinical Study Site
Albury, New South Wales, Australia
-
Clinical Study Site
Wollongong, New South Wales, Australia
-
Clinical Study Site
Fitzroy, Australia
-
Clinical Study Site
Minsk, Belarus
-
Clinical Study Site
Mogilev, Belarus
-
Clinical Study Site
Barretos, Brazil
-
Clinical Study Site
Curitiba, Brazil
-
Clinical Study Site
Joinville, Brazil
-
Clinical Study Site
Lajeado, Brazil
-
Clinical Study Site
Mogi das Cruzes, Brazil
-
Clinical Study Site
Passo Fundo, Brazil
-
Clinical Study Site
Pelotas, Brazil
-
Clinical Study Site
Recife, Brazil
-
Clinical Study Site
Rio de Janeiro, Brazil
-
Clinical Study Site
Salvador, Brazil
-
Clinical Study Site
Santa Cecília, Brazil
-
Clinical Study Site
São José do Rio Preto, Brazil
-
Clinical Study Site
Dobrich, Bulgaria
-
Clinical Study Site
Gabrovo, Bulgaria
-
Clinical Study Site
Recoleta, Chile
-
Clinical Study Site
Santiago, Chile
-
Clinical Study Site
Temuco, Chile
-
Clinical Study Site
Lanshan, Shandong, China
-
Clinical Study Site
Guangdong, China
-
Clinical Study Site
Harbin, China
-
Clinical Study Site
Linyi, China
-
Clinical Study Site
Xuzhou, China
-
Clinical Study Site
Zhejiang, China
-
Clinical Study Site
Barranquilla, Colombia
-
Clinical Study Site
Bogotá, Colombia
-
Clinical Study Site
Floridablanca, Colombia
-
Clinical Study Site
Nový Jičín, Czechia
-
Clinical Study Site
Pelhřimov, Czechia
-
Clinical Study Site
Prague, Czechia
-
Clinical Study Site
Batumi, Georgia
-
Clinical Study Site
Pátrai, Achaia, Greece
-
Clinical Study Site
Cholargós, Attica, Greece
-
Clinical Study Site
Larissa, Greece
-
Clinical Study Site
Pylaia, Greece
-
Clinical Study Site
Gyula, Bekes County, Hungary
-
Clinical Study Site
Tatabánya, Komárom-Esztergom, Hungary
-
Clinical Study Site
Farkasgyepű, Veszprém megye, Hungary
-
Clinical Study Site
Budapest, Hungary
-
Clinical Study Site
Debrecen, Hungary
-
Clinical Study Site
Zalaegerszeg, Hungary
-
Clinical Study Site
Amman, Jordan
-
Clinical Study Site
Irbid, Jordan
-
Clinical Study Site
Bsalîm, Lebanon
-
Clinical Study Site
Mazraat ech Choûf, Lebanon
-
Clinical Study Site
Sidon, Lebanon
-
Clinical Study Site
Kampung Baharu Nilai, Malaysia
-
Clinical Study Site
Kuching, Malaysia
-
Clinical Study Site
Pulau Pinang, Malaysia
-
Clinical Study Site
Tanjong Bungah, Malaysia
-
Clinical Study Site
Coahuila, Mexico
-
Clinical Study Site
Cuautitlán, Mexico
-
Clinical Study Site
Jalisco, Mexico
-
Clinical Study Site
León, Mexico
-
Clinical Study Site
Oaxaca City, Mexico
-
Clinical Study Site
San Luis Potosí City, Mexico
-
Clinical Study Site
Bacolod City, Philippines
-
Clinical Study Site
Batangas, Philippines
-
Clinical Study Site
Cebu, Philippines
-
Clinical Study Site
City of Taguig, Philippines
-
Clinical Study Site
Davao City, Philippines
-
Clinical Study Site
Dąbrowa Górnicza, Poland
-
Clinical Study Site
Gdynia, Poland
-
Clinical Study Site
Krakow, Poland
-
Clinical Study Site
Lodz, Poland
-
Clinical Study Site
Olsztyn, Poland
-
Clinical Study Site
Poznan, Poland
-
Clinical Study Site
Prabuty, Poland
-
Clinical Study Site
Radom, Poland
-
Clinical Study Site
Rzeszów, Poland
-
Clinical Study Site
Torun, Poland
-
Clinical Study Site
Warsaw, Poland
-
Clinical Study Site
Wodzisław Śląski, Poland
-
Clinical Study Site
Floreşti, Romania
-
Clinical Study Site
Ploieşti, Romania
-
Clinical Study Site
Timișoara, Romania
-
Clinical Study Site
Ufa, Republic Bashkortost, Russia
-
Clinical Study Site
Pushkin, Sankt-Peterburg, Russia
-
Clinical Study Site
Arkhangelsk, Russia
-
Clinical Study Site
Belgorod, Russia
-
Clinical Study Site
Chelyabinsk, Russia
-
Clinical Study Site
Kaluga, Russia
-
Clinical Study Site
Kazan', Russia
-
Clinical Study Site
Kemerovo, Russia
-
Clinical Study Site
Kislino, Russia
-
Clinical Study Site
Kursk, Russia
-
Clinical Study Site
Omsk, Russia
-
Clinical Study Site
Pyatigorsk, Russia
-
Clinical Study Site
Samara, Russia
-
Clinical Study Site
Saransk, Russia
-
Clinical Study Site
Sochi, Russia
-
Clinical Study Site
Yekaterinburg, Russia
-
Clinical Study Site
Manresa, Barcelona, Spain
-
Clinical Study Site
Barcelona, Spain
-
Clinical Study Site
Pamplona, Spain
-
Clinical Study Site
Chang-hua, Taiwan
-
Clinical Study Site
Hualien City, Taiwan
-
Clinical Study Site
Hat Yai, Changwat Songkhla, Thailand
-
Clinical Study Site
Lopburi, Muang, Thailand
-
Clinical Study Site
Chiang Rai, Thailand
-
Clinical Study Site
Khon Kaen, Thailand
-
Clinical Study Site
Lampang, Thailand
-
Clinical Study Site
Phitsanulok, Thailand
-
Clinical Study Site
Ratchathewi, Thailand
-
Clinical Study Site
Udon Thani, Thailand
-
Clinical Study Site
Edirne, Turkey (Türkiye)
-
Clinical Study Site
Samsun, Turkey (Türkiye)
-
Clinical Study Site
Dnipro, Ukraine
-
Clinical Study Site
Ivano-Frankivsk, Ukraine
-
Clinical Study Site
Kharkiv, Ukraine
-
Clinical Study Site
Kherson, Ukraine
-
Clinical Study Site
Kirovohrad, Ukraine
-
Clinical Study Site
Uzhhorod, Ukraine
-
Clinical Study Site
Vinnytsia, Ukraine
-
Clinical Study Site
Zaporizhzhya, Ukraine
-
Clinical Study Site #1
Kuala Lumpur, Malaysia
-
Clinical Study Site #1
Quezon City, Philippines
-
Clinical Study Site #1
Bangkok, Thailand
-
Clinical Study Site #2
Kuala Lumpur, Malaysia
-
Clinical Study Site #2
Quezon City, Philippines
-
Clinical Study Site #2
Bangkok, Thailand
-
Clinical Study Site #3
São Paulo, Brazil
-
Clinical Study Site #4
São Paulo, Brazil
-
Clinical Study Site #6
Tbilisi, Georgia
-
Clinical Study Site 1
Porto Alegre, Rio Grande do Sul, Brazil
-
Clinical Study Site 1
São Paulo, Brazil
-
Clinical Study Site 1
Shanghai, China
-
Clinical Study Site 1
Tianjin, China
-
Clinical Study Site 1
Tbilisi, Georgia
-
Clinical Study Site 1
Athens, Greece
-
Clinical Study Site 1
Thessaloniki, Greece
-
Clinical Study Site 1
Monterrey, Mexico
-
Clinical Study Site 1
Manila, Philippines
-
Clinical Study Site 1
Craiova, Romania
-
Clinical Study Site 1
Moscow, Russia
-
Clinical Study Site 1
Saint Petersburg, Russia
-
Clinical Study Site 1
Tomsk, Russia
-
Clinical Study Site 1
Kaohsiung City, Taiwan
-
Clinical Study Site 1
New Taipei City, Taiwan
-
Clinical Study Site 1
Taichung, Taiwan
-
Clinical Study Site 1
Taipei, Taiwan
-
Clinical Study Site 1
Adana, Turkey (Türkiye)
-
Clinical Study Site 1
Ankara, Turkey (Türkiye)
-
Clinical Study Site 1
Istanbul, Turkey (Türkiye)
-
Clinical Study Site 1
Izmir, Turkey (Türkiye)
-
Clinical Study Site 1
Kiev, Ukraine
-
Clinical Study Site 1
Kyiv, Ukraine
-
Clinical Study Site 2
Porto Alegre, Brazil
-
Clinical Study Site 2
São Paulo, Brazil
-
Clinical Study Site 2
Shanghai, China
-
Clinical Study Site 2
Tianjin, China
-
Clinical Study Site 2
Tbilisi, Georgia
-
Clinical Study Site 2
Athens, Greece
-
Clinical Study Site 2
Thessaloniki, Greece
-
Clinical Study Site 2
Monterrey, Mexico
-
Clinical Study Site 2
Manila, Philippines
-
Clinical Study Site 2
Craiova, Romania
-
Clinical Study Site 2
Moscow, Russia
-
Clinical Study Site 2
Saint Petersburg, Russia
-
Clinical Study Site 2
Tomsk, Russia
-
Clinical Study Site 2
Kaohsiung City, Taiwan
-
Clinical Study Site 2
New Taipei City, Taiwan
-
Clinical Study Site 2
Taichung, Taiwan
-
Clinical Study Site 2
Taipei, Taiwan
-
Clinical Study Site 2
Adana, Turkey (Türkiye)
-
Clinical Study Site 2
Ankara, Turkey (Türkiye)
-
Clinical Study Site 2
Istanbul, Turkey (Türkiye)
-
Clinical Study Site 2
Izmir, Turkey (Türkiye)
-
Clinical Study Site 2
Kiev, Ukraine
-
Clinical Study Site 2
Kyiv, Ukraine
-
Clinical Study Site 3
Porto Alegre, Brazil
-
Clinical Study Site 3
Tbilisi, Georgia
-
Clinical Study Site 3
Athens, Greece
-
Clinical Study Site 3
Thessaloniki, Greece
-
Clinical Study Site 3
Monterrey, Mexico
-
Clinical Study Site 3
Moscow, Russia
-
Clinical Study Site 3
Saint Petersburg, Russia
-
Clinical Study Site 3
Taipei, Taiwan
-
Clinical Study Site 3
Ankara, Turkey (Türkiye)
-
Clinical Study Site 3
Istanbul, Turkey (Türkiye)
-
Clinical Study Site 3
Izmir, Turkey (Türkiye)
-
Clinical Study Site 4
Tbilisi, Georgia
-
Clinical Study Site 4
Saint Petersburg, Russia
-
Clinical Study Site 4
Ankara, Turkey (Türkiye)
-
Clinical Study Site 4
Istanbul, Turkey (Türkiye)
-
Clinical Study Site 5
Tbilisi, Georgia
-
Clinical Study Site 5
Ankara, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.